Bariatric surgery remains the most durable long-term option for weight management.1 Although mortality related to bariatric surgery remains low, 6% to 10% of patients can present with morbid adverse events depending on the type of bariatric surgery performed.2 Therapeutic endoscopy has become an accepted first-line approach for the management of most of these adverse events, either by providing definitive therapy or as a bridge to surgical revision.3 Complete dehiscence resulting in separation of the jejunal limb from the gastric pouch (disconnected Roux limb) is an uncommon, yet serious, adverse event.